Erik Manting
Insider Reports History
- Location
- Boston, MA
- Signature
- /s/ Thomas A. Fitzgerald, as Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Erik Manting:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Transcode Therapeutics, Inc. | Director | Stock Option (right to buy) | 70,000 | 14 Jun 2024 | Direct |
Insider Reports Filed by Erik Manting
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RNAZ | Transcode Therapeutics, Inc. | 14 Jun 2024 | 1 | $0 | 4 | Director | 18 Jun 2024, 16:16 |
| RNAZ | Transcode Therapeutics, Inc. | 19 May 2023 | 1 | $0 | 4 | Director | 19 May 2023, 20:09 |
| RNAZ | Transcode Therapeutics, Inc. | 10 May 2023 | 1 | $0 | 4 | Director | 10 May 2023, 18:13 |
| RNAZ | Transcode Therapeutics, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 22 Jun 2022, 20:24 |
| RNAZ | Transcode Therapeutics, Inc. | 08 Jul 2021 | 0 | $0 | 3 | Director | 08 Jul 2021, 21:53 |